Company intelligence / Profile preview

Bluebrim BioScience

Newton, Massachusetts, United Statesbluebrimbio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Bluebrim BioScience is an innovative US-based contract research organization specializing in bioanalytical services for small and large molecules. They provide method development, validation, sample analysis, and data reporting to support drug discovery through preclinical and early clinical studies (Phase I/II). Their expertise includes advanced analytical techniques such as MSD, qPCR/ddPCR, LC-MS/MS, ELISA/ELISpot, flow cytometry, NGS and cell-based assays[1][3][4]. The company is known for its client-centric approach and regulatory compliance with GLP/GCP standards[1][6].

Modalities: Small moleculeLarge moleculeGene therapy (bioanalysis support)Biologic (bioanalysis support)
Industry: Contract Research Organization

Beyond the preview

Go deeper on Bluebrim BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluebrim BioScience.

Explore the full profile